EFFICACY AND TOXICITY OF A NEW SHORT-TERM HIGH INTENSIVE PROTOCOL BL-M-04 FOR ADULT PATIENTS WITH BURKITT LYMPHOMA: INTERMEDIATE RESULTS

被引：0
作者：
Baryakh, E. A. [1 ]
Kravchenco, S. K. [1 ]
Kremenetskaja, A. M. [1 ]
Zvonkov, E. E. [1 ]
Vorobjov, A. I. [1 ]
机构：
[1] Russian Hematol Sci Ctr, Moscow, Russia
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0988
引用
收藏
页码：393 / 394
页数：2
相关论文
共 39 条
  • [21] Intensive chemotherapy for Burkitt's lymphoma and leukemia:: Similar results for HIV positive and negative adult patients treated with PETHEMA ALL3/97 protocol.
    Ribera, JM
    Oriol, A
    Esteve, J
    Rovira, M
    Brunet, S
    Sierra, J
    Sanz, MA
    Martín, G
    García-Boyero, R
    Peñarrubia, MD
    Abella, E
    Besalduch, J
    Sánchez-Delgado, M
    Fernandez-Abellán, P
    Pérez, I
    Deben, G
    Borrego, D
    Guinea, J
    Montserrat, E
    Feliu, E
    [J]. BLOOD, 2001, 98 (11) : 343A - 343A
  • [22] Feasibility and Toxicity of a Modified Dose Intensive R- CODOX-M/IVAC for HIV-Associated Burkitt and Atypical Burkitt Lymphoma(BL): Preliminary Results of a Prospective Multicenter Phase II Trial of the AIDS Malignancy Consortium (AMC)
    Noy, Ariela
    Kaplan, Lawrence
    Lee, Jeannette
    [J]. BLOOD, 2009, 114 (22) : 1415 - 1416
  • [23] Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with features intermediate between diffuse large B cell lymphoma and BL
    Maruyama, Dai
    Watanabe, Takashi
    Maeshima, Akiko Miyagi
    Nomoto, Junko
    Taniguchi, Hirokazu
    Azuma, Teruhisa
    Mori, Masakazu
    Munakata, Wataru
    Kim, Sung-Won
    Kobayashi, Yukio
    Matsuno, Yoshihiro
    Tobinai, Kensei
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 92 (05) : 732 - 743
  • [24] Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with features intermediate between diffuse large B cell lymphoma and BL
    Dai Maruyama
    Takashi Watanabe
    Akiko Miyagi Maeshima
    Junko Nomoto
    Hirokazu Taniguchi
    Teruhisa Azuma
    Masakazu Mori
    Wataru Munakata
    Sung-Won Kim
    Yukio Kobayashi
    Yoshihiro Matsuno
    Kensei Tobinai
    [J]. International Journal of Hematology, 2010, 92 : 732 - 743
  • [25] SHORT-TERM WEEKLY CHEMOTHERAPY FOLLOWED BY HIGH-DOSE THERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR LYMPHOBLASTIC AND BURKITT LYMPHOMAS IN ADULT PATIENTS
    JOST, LM
    JACKY, E
    DOMMANNSCHERRER, C
    HONEGGER, HP
    MAURER, R
    SAUTER, C
    STAHEL, RA
    [J]. ANNALS OF ONCOLOGY, 1995, 6 (05) : 445 - 451
  • [26] Proton Irradiation using the Pencil Beam Scanning Technology for Patients with mediastinal Hodgkin's Lymphoma: acute Toxicity and short-term therapeutic Results
    Dedeckova, K.
    Kubes, J.
    Zapletalova, S.
    Mocikova, H.
    Markova, J.
    Gaherova, L.
    Kaliska, L.
    Andrlik, M.
    Vondracek, V.
    Koren, J.
    Vackova, B.
    Feltl, D.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S22 - S22
  • [27] An investigation of the efficacy and safety of remifentanil for the provision of optimal sedation in adult ICU patients requiring short-term mechanical ventilation: preliminary results
    B Muellejans
    A Lopez
    MH Cross
    C Bonome
    L Morrison
    A Kirkham
    [J]. Critical Care, 5 (Suppl 1):
  • [28] HIGH EFFICACY OF SHORT-TERM QUININE-ANTIBIOTIC COMBINATIONS FOR TREATING ADULT MALARIA PATIENTS IN AN AREA IN WHICH MALARIA IS HYPERENDEMIC
    METZGER, W
    MORDMULLER, B
    GRANINGER, W
    BIENZLE, U
    KREMSNER, PG
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (01) : 245 - 246
  • [29] A Modified Dose Intensive R- CODOX-M/IVAC For HIV-Associated Burkitt and Atypical Burkitt Lymphoma(BL) Demonstrates High Cure Rates and Low Toxicity: Prospective Multicenter Phase II Trial Of The AIDS Malignancy Consortium (AMC 048)
    Noy, Ariela
    Kaplan, Lawrence
    Lee, Jeannette Y.
    [J]. BLOOD, 2013, 122 (21)
  • [30] Incorporation of rituximab and liposomal doxorubicin into CODOX-m/IVAC for HIV-negative and HIV-positive adult patients (pts) with untreated Burkitt's lymphoma (BL): Preliminary results of a multicenter phase II study
    Gregory, S. A.
    Barr, P. M.
    Nabhan, C.
    Nukala, A.
    Gallot, L.
    Larsen, A.
    Moll, M. Z.
    Smith, S. E.
    Gordon, L. I.
    Evens, A. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
1234